Qiagen has launched the QuantiFeron SARS-CoV-2 Research Use Only (RUO) solution to detect T-cell responses to the novel coronavirus. The solution could aid researchers in investigating the cause, spread, and control of COVID-19.
QuantiFeron SARS-CoV-2 ROU is a modular system based on the platform Qiagen developed for its QuantiFeron-TB Gold Plus test for latent tuberculosis.
Potential uses of the system include determining how long T-cell response and any associated SARS-CoV-2 immunity lasts. Researchers could also study whether T-cell response can indicate disease severity, the company noted.
QuantiFeron SARS-CoV-RUO is the latest addition to Qiagen's COVID-19 portfolio of products. Other COVID-19 solutions include sample-preparation technology and tests for SARS-CoV-2 infection, antibodies, and antigens.
